Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fleming

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
The Biochemical Journal|July 25, 1998
Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiationI Fleming, S J MacKenzie, R G Vernon, et al.
Plastic and Reconstructive Surgery. Global Open|July 20, 2019
Double-Blind Randomized Clinical Trial to Examine the Pharmacokinetic and Clinical Impacts of Fixed Dose versus Weight-based Enoxaparin Prophylaxis: A Methodologic Description of the FIxed or Variable Enoxaparin (FIVE) TrialChristopher J Pannucci, Kory I Fleming, Corinne Bertolaccini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2000
Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2+) changes and dilation in isolated resistance arteriesS S Bolz, B Fisslthaler, S Pieperhoff, et al.
Plastic and Reconstructive Surgery|April 3, 2018
Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day BleedingChristopher J Pannucci, Kory I Fleming, Arash Momeni, et al.
The Annals of Thoracic Surgery|April 8, 2018
Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical ProcedureChristopher J Pannucci, Kory I Fleming, Kathleen Holoyda, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1990
Local-regional non-rhabdomyosarcomatous soft tissue sarcomas of the head and neckJ Fontanesi, C Pratt, L Kun, et al.
Virchows Archiv : an International Journal of Pathology|April 27, 2000
Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis)D Scholz, W Ito, I Fleming, et al.
JAMA Surgery|May 23, 2019
Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin PharmacokineticsChristopher J Pannucci, Kory I Fleming, Corinne B Bertolaccini, et al.
Plos One|December 29, 2010
Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoterNicholas I Fleming, Kevin C Knower, Kyren A Lazarus, et al.
The Annals of Thoracic Surgery|February 12, 2020
Fixed or Weight-Tiered Enoxaparin After Thoracic Surgery for Venous Thromboembolism PreventionChristopher J Pannucci, Kory I Fleming, Corinne Bertolaccini, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
The Biochemical Journal|July 25, 1998
Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiationI Fleming, S J MacKenzie, R G Vernon, et al.
Plastic and Reconstructive Surgery. Global Open|July 20, 2019
Double-Blind Randomized Clinical Trial to Examine the Pharmacokinetic and Clinical Impacts of Fixed Dose versus Weight-based Enoxaparin Prophylaxis: A Methodologic Description of the FIxed or Variable Enoxaparin (FIVE) TrialChristopher J Pannucci, Kory I Fleming, Corinne Bertolaccini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2000
Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2+) changes and dilation in isolated resistance arteriesS S Bolz, B Fisslthaler, S Pieperhoff, et al.
Plastic and Reconstructive Surgery|April 3, 2018
Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day BleedingChristopher J Pannucci, Kory I Fleming, Arash Momeni, et al.
The Annals of Thoracic Surgery|April 8, 2018
Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical ProcedureChristopher J Pannucci, Kory I Fleming, Kathleen Holoyda, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1990
Local-regional non-rhabdomyosarcomatous soft tissue sarcomas of the head and neckJ Fontanesi, C Pratt, L Kun, et al.
Virchows Archiv : an International Journal of Pathology|April 27, 2000
Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis)D Scholz, W Ito, I Fleming, et al.
JAMA Surgery|May 23, 2019
Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin PharmacokineticsChristopher J Pannucci, Kory I Fleming, Corinne B Bertolaccini, et al.
Plos One|December 29, 2010
Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoterNicholas I Fleming, Kevin C Knower, Kyren A Lazarus, et al.
The Annals of Thoracic Surgery|February 12, 2020
Fixed or Weight-Tiered Enoxaparin After Thoracic Surgery for Venous Thromboembolism PreventionChristopher J Pannucci, Kory I Fleming, Corinne Bertolaccini, et al.
Pageof 15